Development of Drugs with Direct Antiviral Action Based on Azaheterocyclic Systems

This article discusses the results of studies carried out in recent years by a team of scientists from the Postovskii Institute of Organic Synthesis, Ural Branch, Russian Academy of Sciences, in cooperation with the First President of Russia Boris Yeltsin Ural Federal University, Ural State Medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Charushin, V. N., Rusinov, V. L., Varaksin, M. V., Chupakhin, O. N., Kovtun, O. P., Spasov, A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2022
Materias:
Scientific Session of the General Meeting of the RAS Members “The Role of Science in Overcoming Pandemics and Postcrisis Development of Society”
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447972/
https://www.ncbi.nlm.nih.gov/pubmed/36091844
http://dx.doi.org/10.1134/S1019331622040104
Descripción
Sumario:This article discusses the results of studies carried out in recent years by a team of scientists from the Postovskii Institute of Organic Synthesis, Ural Branch, Russian Academy of Sciences, in cooperation with the First President of Russia Boris Yeltsin Ural Federal University, Ural State Medical University, Volgograd State Medical University, and other scientific and production organizations of the country to create triazavirin (riamilovir) and other direct etiotropic antiviral drugs based on azaheterocyclic derivatives.

Ejemplares similares